Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Sex | Ā | Ā | 0.106 | Ā | Ā | Ā |
āMale | Reference | Ā | Ā | Ā | Ā | Ā |
āFemale | NA | NA | Ā | Ā | Ā | Ā |
Age, years | Ā | Ā | 0.097 | Ā | Ā | Ā |
āāā¤ā60 | Reference | Ā | Ā | Ā | Ā | Ā |
āā>ā60 | NA | NA | Ā | Ā | Ā | Ā |
Tumor size, cm | Ā | Ā | 0.575 | Ā | Ā | Ā |
āāā¤ā2 | Reference | Ā | Ā | Ā | Ā | Ā |
āā>ā2 | NA | NA | Ā | Ā | Ā | Ā |
Symptoms | Ā | Ā | 0.039 | Ā | Ā | 0.168 |
āAbsent | Reference | Ā | Ā | Reference | Ā | Ā |
āPresent | 4.768 | 1.084ā20.982 | Ā | NA | NA | Ā |
Tumor location | Ā | Ā | 0.424 | Ā | Ā | Ā |
āHead/uncinate/neck | Reference | Ā | Ā | Ā | Ā | Ā |
āBody/tail | NA | NA | Ā | Ā | Ā | Ā |
T-stage | Ā | Ā | 0.12 | Ā | Ā | Ā |
āT1ā2 | Reference | Ā | Ā | Ā | Ā | Ā |
āT3ā4 | NA | NA | Ā | Ā | Ā | Ā |
Perineural invasion | Ā | Ā | 0.019 | Ā | Ā | 0.430 |
āAbsent | Reference | Ā | Ā | Reference | Ā | Ā |
āPresent | 3.870 | 1.246ā12.023 | Ā | NA | NA | Ā |
LN metastasis | Ā | Ā | <ā0.001 | Ā | Ā | 0.784 |
āAbsent | Reference | Ā | Ā | Reference | Ā | Ā |
āPresent | 11.916 | 4.433ā32.028 | Ā | NA | NA | Ā |
Distant metastasis | Ā | Ā | <ā0.001 | Ā | Ā | 0.690 |
āAbsent | Reference | Ā | Ā | Reference | Ā | Ā |
āPresent | 10.102 | 3.252ā31.380 | Ā | NA | NA | Ā |
WHO classification | Ā | Ā | 0.010 | Ā | Ā | 0.540 |
āGrade 1 | Reference | Ā | Ā | Reference | Ā | Ā |
āGrade 2 | 5.253 | 1.496ā18.443 | Ā | NA | NA | Ā |
AJCC stage | Ā | Ā | <ā0.001 | Ā | Ā | <ā0.001 |
āI-II | Reference | Ā | Ā | Reference | Ā | Ā |
āIII-IV | 18.602 | 5.996ā57.709 | Ā | 8.646 | 2.645ā28.261 | Ā |
EMT markers | Ā | Ā | <ā0.001 | Ā | Ā | <ā0.001 |
āOther group | Reference | Ā | Ā | Reference | Ā | Ā |
High vimentin and lost E-cadherin expression group | 20.888 | 5.951ā73.318 | Ā | 10.388 | 2.794ā38.625 | Ā |